Usana Health Sciences
USNA
154 hedge funds and large institutions have $463M invested in Usana Health Sciences in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 60 reducing their positions, and 26 closing their positions.
4% more call options, than puts
Call options by funds: $145K | Put options by funds: $140K
0.8% more ownership
Funds ownership: 52.92% → 53.72% (+0.8%)
4% less funds holding
Funds holding: 161 → 154 (-7)
6% less capital invested
Capital invested by funds: $494M → $463M (-$31M)
17% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 60
19% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pzena Investment Management
New York
|
+$8.8M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$2.7M |
| 3 |
TI
Trexquant Investment
Stamford,
Connecticut
|
+$1.54M |
| 4 |
D.E. Shaw & Co
New York
|
+$1.48M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$2.79M |
| 2 |
BlackRock
New York
|
-$2.19M |
| 3 |
WCF
West Coast Financial
Santa Barbara,
California
|
-$2.16M |
| 4 |
Renaissance Technologies
New York
|
-$1.99M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$1.84M |
USNA Hedge Fund Activity: Q2 2024 in Review
154 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q2 2024, worth a combined $463M — down 6.3% from $494M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of USNA and 21 opened new positions — a net loss of 5 holders — while 60 trimmed existing stakes and 50 added.
The largest buyer was Pzena Investment Management, adding an estimated $8.8M. The largest seller was First Trust Advisors, exiting entirely with an estimated $2.79M sold.
- 154 institutional investors held Usana Health Sciences (USNA) as of Q2 2024, down from 161 in Q1 2024.
- Funds reported $463M of Usana Health Sciences stock for Q2 2024, down 6.3% quarter-over-quarter.
- 21 funds opened new Usana Health Sciences positions in Q2 2024 and 26 closed out, a net change of -5 holders.
- The largest Usana Health Sciences buyer in Q2 2024 was Pzena Investment Management, an estimated $8.8M added.
- The largest Usana Health Sciences seller in Q2 2024 was First Trust Advisors, an estimated $2.79M sold.
Based on aggregated 13F filings for Q2 2024.